ISRCTN77277298已完成不适用
Phase III study on the efficacy and safety of Hypericum extract WS® 5570 in patients with a Major Depressive Episode
Schwabe Pharmaceuticals (Germany)0 个研究点目标入组 320 人开始时间: 2005年12月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Diagnosis of a major depressive episode according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (single episode: 296.21, 296.22, recurrent episode: 296.31, 296.32)
- •2. Severity of depression on the baseline visit: Hamilton rating scale for depression (17-HAMD) total score =18 and HAMD item 'depressive mood' =2
排除标准
- •1. Any of the following psychiatric diagnosis according to DSM-IV: schizophrenia (295.x, 297.x, 298.x), acute anxiety disorder (300.x, 302.x) as primary diagnosis, adjustment disorder (309.x), episodes of depression with any characteristics of a psychotic nature (296.24, 296.34), depressive disorders not defined as inclusion criteria (e.g. 300.4, 311), bipolar disorder (296.0, 296.4, 296.5, 296.6, 296.7, 296.8, 301.13), organic mental disorder (International Statistical Classification of Diseases and Related Health Problems - tenth revision [ICD-10]: F06), acute post traumatic stress disorder (309.81), abuse of any substance; risk of suicide
- •2. Lack of response to any adequate antidepressant therapy in the present episode
- •3. Duration of the index episode greater than 1 year
- •4. Concomitant medication with any psychotropic drug
- •5. Any clinical relevant hepatic, renal, cardiovascular, respiratory, cerebrovascular, metabolic disorder or progressive diseases
研究者
相似试验
尚未招募
2 期
A Clinical trial to study the effect of two drugs, Ropivacaine and Bupivacaine in patient undergoing lower limb surgeryCTRI/2024/07/070422B J Medical College and Civil Hospital Ahmedabad Government of Gujarat
进行中（未招募）
1 期
Clinical study to assess the efficacy and safety of gene therapy for the treatment of childhood cerebral adrenoleukodystrophyChildhood Cerebral Adrenoleukodystrophy (CCALD)MedDRA version: 18.0Level: PTClassification code 10051260Term: AdrenoleukodystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-001953-10-FRbluebird bio, Inc.15
进行中（未招募）
1 期
Clinical study to assess the efficacy and safety of gene therapy for the treatment of cerebral adrenoleukodystrophyCerebral Adrenoleukodystrophy (CALD)MedDRA version: 20.0Level: PTClassification code 10051260Term: AdrenoleukodystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-001953-10-DEbluebird bio, Inc.32
进行中（未招募）
3 期
A study to assess the safety and efficacy of a gel treatment in subjects with acne vulgarisAcne vulgarisSkin and Connective Tissue DiseasesISRCTN18067422PPM Services S.A400
招募中
2 期
A study to find out the effectiveness of oral temozolomide along with radiation in patients with grade IV glial tumors using a short course of Intensity modulated RadiotherapyCTRI/2021/01/030334Christian Medical College Vellore